For instance, catalytic m6A-modified methyltransferase-like 3 (METTL3) is highly expressed in malignancies such as cholangiocarcinoma, thymoma, and diffuse large B-cell tumours according to the GEPIA website (https://gepia.cancer-pku.cn). Here, METTL3 is linked to cholangiocarcinoma.